Introducing Empower Software for SEC-MALS: Enhanced Compliance Suite for Development and QC
Presented by: Tracy Hibbs and Colette Quinn, Waters Corporation
Presented Live: May 29, 2025
The newly released Empower™ Software is the first platform to integrate MALS acquisition and analysis into enterprise-wide workflows. DAWN™ and miniDAWN™ MALS instruments users can now leverage the extensive and compliance-ready features within Empower software for final development and QC. Empower software users now benefit from enhanced capabilities for thorough size variant analysis and SEC-MALS characterization.
Join us to explore the new Empower SEC-MALS release and its applications in biotherapeutic development and QC, featuring case studies on monoclonal antibodies and peptides. Learn about the latest Empower features that streamline characterization, helping you navigate the complexities of an evolving regulatory landscape.